Elite Life Management’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1M Buy
167,050
+3,117
+2% +$217K 14.15% 3
2026
Q1
$11.6M Buy
163,933
+1,923
+1% +$127K 14.52% 3
2025
Q4
$10.9M Buy
162,010
+2,805
+2% +$172K 17.71% 2
2025
Q3
$9.62M Buy
159,205
+20,386
+15% +$1.19M 19.63% 2
2025
Q2
$7.91M Buy
138,819
+17,438
+14% +$934K 20.37% 2
2025
Q1
$6.17M Buy
121,381
+10,379
+9% +$525K 19.25% 2
2024
Q4
$5.31M Buy
111,002
+11,547
+12% +$580K 15.72% 2
2024
Q3
$5.25M Buy
99,455
+6,903
+7% +$351K 17.16% 2
2024
Q2
$4.57M Buy
92,552
+13,158
+17% +$655K 17.74% 1
2024
Q1
$3.98M Buy
79,394
+5,800
+8% +$280K 19.5% 1
2023
Q4
$3.53M Buy
+73,594
New +$3.29M 21.1% 1

Other funds holding VEA

Elite Life Management's VEA Position: Q2 2026 in Review

Elite Life Management increased its Vanguard FTSE Developed Markets ETF (VEA) stake by 1.9% in Q2 2026, buying an estimated $217K and bringing the position to 167,050 shares worth $12.1M. The position accounts for 14.15% of the portfolio, ranked #3.

Elite Life Management first reported a position in VEA in Q4 2023 and has held it in 11 quarters since. 2,992 funds tracked by Wall St. Rank hold VEA as of Q2 2026.

  • Elite Life Management held 167,050 shares of Vanguard FTSE Developed Markets ETF worth $12.1M as of Q2 2026.
  • Elite Life Management bought 3,117 Vanguard FTSE Developed Markets ETF shares in Q2 2026, an estimated $217K.
  • Vanguard FTSE Developed Markets ETF made up 14.15% of Elite Life Management's portfolio in Q2 2026, its #3 holding.
  • Elite Life Management first reported a position in Vanguard FTSE Developed Markets ETF in Q4 2023 and has held it in 11 quarters since.
  • 2,992 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2026.

Based on Elite Life Management's 13F filing for Q2 2026, filed 6 Aug 2026.